PAB
@Rory, The clinical trials at Yale for Deoxymab are looking extremely positive, this progress can be accessed in Medical Journal Online.In my view they will have a huge announcement on this very soon!! PAB hinted on this in their annual report.The outcomes should be very big globally for PAB..Certainly worth more than their $4M Cap.
"Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).
THIS IS WHAT TO WATCH FOR IN THE COMING ANNOUNCEMENT.
GL
PAB @Rory, The clinical trials at Yale for Deoxymab are looking...
-
- There are more pages in this discussion • 172 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)